Telix Pharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is $0.008; its P/E ratio is 949.44; Telix Pharmaceuticals Ltd. is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 116.33M	AU$ 22.04M	AU$ 77.94M	AU$ 44.60M	AU$ 25.77M
Total Assets	AU$ 255.35M	AU$ 109.81M	AU$ 157.82M	AU$ 102.61M	AU$ 76.71M
Total Debt	AU$ 10.45M	AU$ 2.54M	AU$ 2.21M	AU$ 2.13M	AU$ 1.73M
Net Debt	AU$ -105.88M	AU$ -19.50M	AU$ -75.74M	AU$ -42.47M	AU$ -24.04M
Total Liabilities	AU$ 175.35M	AU$ 107.66M	AU$ 78.81M	AU$ 32.53M	AU$ 23.80M
Stockholders Equity	AU$ 80.01M	AU$ 2.16M	AU$ 79.02M	AU$ 70.08M	AU$ 52.90M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Telix Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Telix Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Telix Pharmaceuticals Ltd. Cash Flow

Cash Flow >

Telix Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing